CVS HEALTH Corp·4

Dec 3, 5:15 PM ET

Joyner J. David 4

4 · CVS HEALTH Corp · Filed Dec 3, 2024

Insider Transaction Report

Form 4
Period: 2024-11-30
Joyner J. David
DirectorPresident and CEO
Transactions
  • Award

    Premium Stock Option

    2024-11-30$71.82/sh+1,492,537$107,194,0071,492,537 total
    Exercise: $71.82From: 2025-11-30Exp: 2031-11-30Common Stock (1,492,537 underlying)
Holdings
  • Common Stock (Restricted)

    44,241
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (51,959 underlying)
    51,959
  • Common Stock

    40,681
Footnotes (2)
  • [F1]Option became exercisable in four equal annual installments, commencing 4/1/2024.
  • [F2]Option becomes exercisable in three equal annual installments, commencing 11/30/2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT